A. Maria

2.4k total citations
54 papers, 1.0k citations indexed

About

A. Maria is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Maria has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 17 papers in Genetics and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Maria's work include Systemic Sclerosis and Related Diseases (24 papers), Mesenchymal stem cell research (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). A. Maria is often cited by papers focused on Systemic Sclerosis and Related Diseases (24 papers), Mesenchymal stem cell research (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). A. Maria collaborates with scholars based in France, Canada and Martinique. A. Maria's co-authors include Philippe Guilpain, Christian Jørgensen, Alain Le Quellec, Danièle Noël, Marie Maumus, Karine Toupet, Pauline Rozier, Sophie Rivière, Radjiv Goulabchand and Isabelle Touitou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

A. Maria

47 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Maria France	19	372	317	286	195	192	54	1.0k
Anne Moreau France	16	350 0.9×	221 0.7×	212 0.7×	257 1.3×	151 0.8×	40	1.3k
Ayşegül Üner Türkiye	17	265 0.7×	166 0.5×	283 1.0×	177 0.9×	107 0.6×	81	978
Christoph Deuter Germany	23	199 0.5×	107 0.3×	273 1.0×	154 0.8×	225 1.2×	85	1.9k
Karen P. Mann United States	21	656 1.8×	197 0.6×	233 0.8×	318 1.6×	93 0.5×	46	1.5k
L Boudová Czechia	17	481 1.3×	162 0.5×	305 1.1×	88 0.5×	383 2.0×	56	1.1k
Paolo Fraticelli Italy	16	948 2.5×	154 0.5×	352 1.2×	866 4.4×	323 1.7×	38	2.1k
Christophe Bédane France	17	906 2.4×	673 2.1×	124 0.4×	131 0.7×	155 0.8×	57	1.5k
Mathilde de Menthon France	12	183 0.5×	69 0.2×	136 0.5×	188 1.0×	381 2.0×	26	1.1k
David J. Kouba United States	21	228 0.6×	103 0.3×	326 1.1×	72 0.4×	169 0.9×	63	1.5k
Mazen S. Daoud United States	18	414 1.1×	205 0.6×	133 0.5×	87 0.4×	438 2.3×	31	1.3k

Countries citing papers authored by A. Maria

Since Specialization

Citations

This map shows the geographic impact of A. Maria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Maria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Maria more than expected).

Fields of papers citing papers by A. Maria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Maria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Maria. The network helps show where A. Maria may publish in the future.

Co-authorship network of co-authors of A. Maria

This figure shows the co-authorship network connecting the top 25 collaborators of A. Maria. A scholar is included among the top collaborators of A. Maria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Maria. A. Maria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faure, Stéphanie, et al.. (2025). Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury. Liver International. 45(5). e70073–e70073.

Sibaud, V., A. Maria, Emmanuelle Uro‐Coste, et al.. (2025). Immune checkpoint inhibitor-related eosinophilic fasciitis: 3 case reports with literature review. La Revue de Médecine Interne. 46(7). 377–385.

Maria, A., et al.. (2024). Dermatomyosites induites par les Inhibiteurs du Checkpoint Immunologique : série de cas, recueil issu de la base de pharmacovigilance VigiBase et revue de la littérature. La Revue de Médecine Interne. 45. A127–A128. 1 indexed citations

Faure, Stéphanie, Marie Dupuy, Dominique Larrey, et al.. (2024). Time to use the right classification to predict the severity of checkpoint inhibitor‐induced liver injury, as assessed for causality using the updated RUCAM. Alimentary Pharmacology & Therapeutics. 60(11-12). 1561–1572. 6 indexed citations

Farge, Dominique, G. Pugnet, Matthieu Allez, et al.. (2024). French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases. La Revue de Médecine Interne. 45(2). 79–99. 2 indexed citations

Lebossé, Fanny, Xavier Quantin, C. Lesage, et al.. (2023). Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort. JHEP Reports. 5(6). 100719–100719. 43 indexed citations

Maria, A., et al.. (2023). Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102192–102192. 1 indexed citations

Duflos, Claire, et al.. (2023). Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study. ESMO Open. 8(6). 102070–102070. 2 indexed citations

Maria, A., Cristina Castilla‐Llorente, Pauline Lansiaux, et al.. (2023). Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC. Bulletin du Cancer. 110(2). S97–S107.

10.

Morel, Jacques, William Jacot, Christian Jørgensen, et al.. (2023). Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjögren’s syndrome. Cancer Immunology Immunotherapy. 72(12). 4309–4322. 3 indexed citations

11.

Goulabchand, Radjiv, Damien Etchecopar‐Etchart, A. Maria, et al.. (2022). The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients. Scientific Reports. 12(1). 13176–13176. 18 indexed citations

12.

Farge, Dominique, Séverine Loisel, Matthieu Resche‐Rigon, et al.. (2022). Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study. The Lancet Rheumatology. 4(2). e91–e104. 23 indexed citations

13.

Brès, Virginie, et al.. (2022). Comprehensive description of adult-onset Still's disease after COVID-19 vaccination. Journal of Autoimmunity. 134. 102980–102980. 5 indexed citations

14.

Quantin, Xavier, Jean‐Luc Faillie, C. Lesage, et al.. (2021). Gestion des toxicités induites par les inhibiteurs de checkpoint immunologique : données de la réunion de concertation pluridisciplinaire « ToxImmun » en Occitanie Est. La Revue de Médecine Interne. 42(5). 310–319. 4 indexed citations

15.

Lansiaux, Pauline, Séverine Loisel, Cristina Castilla‐Llorente, et al.. (2021). Suivi immunologique et collection biologique en vue de l’analyse de la réponse clinique après autogreffe de moelle pour maladies auto-immunes : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 108(12). S72–S81. 2 indexed citations

16.

Rozier, Pauline, Marie Maumus, A. Maria, et al.. (2021). Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p. Journal of Autoimmunity. 121. 102660–102660. 53 indexed citations

17.

Boysson, Hubert de, M. Le Besnerais, Aurélie Daumas, et al.. (2021). Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis. Arthritis Research & Therapy. 23(1). 143–143. 9 indexed citations

18.

Duflos, Claire, Rosanna Ferreira, Saïd Assou, et al.. (2021). Identification of a Novel Serum Proteomic Signature for Primary Sjögren’s Syndrome. Frontiers in Immunology. 12. 631539–631539. 12 indexed citations

19.

Rullier, P., Hélène Perrochia, Moglie Le Quintrec, et al.. (2021). Glomérulonéphrite membrano-proliférative post-grippale chez un patient atteint de mastocytose systémique agressive : observation commentée et revue de la littérature. Néphrologie & Thérapeutique. 18(2). 140–143. 1 indexed citations

20.

Maria, A., Karine Toupet, Marie Maumus, et al.. (2018). Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells. Frontiers in Immunology. 9. 2571–2571. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact